AbCellera Plans 2027 Late-Stage Development for ABCL635

Your call?🐂 Bullish🐻 Bearish

A Phase 2 study found a placebo-adjusted reduction of 5.3 moderate-to-severe hot flashes per day at week four. AbCellera listed more than $890 million in available liquidity as of Sept. 30.